← Back to Cibo Flash
Earnings

Sinco Pharma (06833) announced interim results

  • RevenueRMB10.3bn
  • Net profitRMB19.9M
  • Profit attributable to ownersRMB19.9M
  • Revenue YoY-13.7%
  • Net profit YoY-18.4%
  • Depreciation & amortisationHK$25.6M
  • Capital expenditureHK$-27.8M
  • Interest-bearing debtHK$1.8bn

Source Sinco Pharma

Cibo — HK IPO Allotment Forecasts, Allottee Profiling & Stock Connect